Pipeline – FLT4
About FLT4
Flt4, as well as being a driver in lymph angiogenesis, controls the mobilisation of cancer cells, a key process involved in metastasis, the main cause of death in cancer patients. A drug inhibiting Flt4 should prevent tumour spread and provide an invaluable therapy for the management of many cancer types.
Sareum have discovered potent inhibitors of FLT4 which are currently being pursued in late stage lead optimisation.
Requires RSS news reader
Requires MS Word
Requires Adobe Acrobat Reader